Cargando…

Splice variants as novel targets in pancreatic ductal adenocarcinoma

Despite a wealth of genomic information, a comprehensive alternative splicing (AS) analysis of pancreatic ductal adenocarcinoma (PDAC) has not been performed yet. In the present study, we assessed whole exome-based transcriptome and AS profiles of 43 pancreas tissues using Affymetrix exon array. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jun, Dumartin, Laurent, Mafficini, Andrea, Ulug, Pinar, Sangaralingam, Ajanthah, Alamiry, Namaa Audi, Radon, Tomasz P., Salvia, Roberto, Lawlor, Rita T., Lemoine, Nicholas R., Scarpa, Aldo, Chelala, Claude, Crnogorac-Jurcevic, Tatjana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462735/ https://www.ncbi.nlm.nih.gov/pubmed/28592875 http://dx.doi.org/10.1038/s41598-017-03354-z

Ejemplares similares

A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma
por: Haider, Syed, et al.
Publicado: (2014)

Pancreatic Expression database: a generic model for the organization, integration and mining of complex cancer datasets
por: Chelala, Claude, et al.
Publicado: (2007)

O-miner: an integrative platform for automated analysis and mining of -omics data
por: Cutts, Rosalind J., et al.
Publicado: (2012)

The Pancreatic Expression database: 2011 update
por: Cutts, Rosalind J., et al.
Publicado: (2011)

Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma
por: Goulart, Michelle R., et al.
Publicado: (2021)

Molecular Analysis of Precursor Lesions in Familial Pancreatic Cancer
por: Crnogorac-Jurcevic, Tatjana, et al.
Publicado: (2013)

AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting
por: Liu, Alvin Y., et al.
Publicado: (2019)

A global insight into a cancer transcriptional space using pancreatic data: importance, findings and flaws
por: Gadaleta, Emanuela, et al.
Publicado: (2011)

Nutraceuticals as Supportive Therapeutic Agents in Diabetes and Pancreatic Ductal Adenocarcinoma: A Systematic Review
por: Mikolaskova, Iveta, et al.
Publicado: (2023)

Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling
por: Alrawashdeh, Wasfi, et al.
Publicado: (2019)

ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation
por: Dumartin, L, et al.
Publicado: (2017)

The Pancreatic Expression Database: 2018 update
por: Marzec, Jacek, et al.
Publicado: (2018)

‘Multi-omic’ data analysis using O-miner
por: Sangaralingam, Ajanthah, et al.
Publicado: (2017)

The pancreatic expression database: recent extensions and updates
por: Dayem Ullah, Abu Z., et al.
Publicado: (2014)

Response to the comment on “Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients”
por: Blyuss, Oleg, et al.
Publicado: (2020)

On the artefactual parasitic eubacteria clan in conditioned logdet phylogenies: heterotachy and ortholog identification artefacts as explanations
por: Sangaralingam, Ajanthah, et al.
Publicado: (2010)

MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma
por: Bladen, John C., et al.
Publicado: (2018)

Non-Invasive Biomarkers for Earlier Detection of Pancreatic Cancer—A Comprehensive Review
por: Brezgyte, Greta, et al.
Publicado: (2021)

Demographic, clinical, and pathological features of early onset pancreatic cancer patients
por: Ntala, Chara, et al.
Publicado: (2018)

Non-coding regulatory variations: the dark matter of pancreatic cancer genomics
por: Scarpa, Aldo, et al.
Publicado: (2018)

Genomic landscape of pancreatic neuroendocrine tumours: the International Cancer Genome Consortium
por: Mafficini, Andrea, et al.
Publicado: (2018)

Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms
por: Mafficini, Andrea, et al.
Publicado: (2019)

Gene expression profiling of breast cancer in Lebanese women
por: Makoukji, Joelle, et al.
Publicado: (2016)

Non-Invasive Biomarkers for Early Lung Cancer Detection
por: Saman, Harman, et al.
Publicado: (2022)

Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies
por: Schröder, Christoph, et al.
Publicado: (2010)

Discovery of novel small molecule inhibitors of S100P with in vitro anti-metastatic effects on pancreatic cancer cells
por: Camara, Ramatoulie, et al.
Publicado: (2020)

Association between CLN3 (Neuronal Ceroid Lipofuscinosis, CLN3 Type) Gene Expression and Clinical Characteristics of Breast Cancer Patients
por: Makoukji, Joelle, et al.
Publicado: (2015)

KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities
por: Luchini, Claudio, et al.
Publicado: (2020)

Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group
por: Sorio, Claudio, et al.
Publicado: (2011)

DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples
por: Simbolo, Michele, et al.
Publicado: (2013)

Prognostic Role of High-Grade Tumor Budding in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis with a Focus on Epithelial to Mesenchymal Transition
por: Lawlor, Rita T., et al.
Publicado: (2019)

microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells
por: Mortoglou, Maria, et al.
Publicado: (2022)

Histo-molecular oncogenesis of pancreatic cancer: From precancerous lesions to invasive ductal adenocarcinoma
por: Riva, Giulio, et al.
Publicado: (2018)

S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer
por: Srivastava, K., et al.
Publicado: (2023)

Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications
por: Luchini, Claudio, et al.
Publicado: (2021)

Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors
por: Barry, Sayka, et al.
Publicado: (2019)

Solid Pseudopapillary Neoplasm of the Pancreas and Abdominal Desmoid Tumor in a Patient Carrying Two Different BRCA2 Germline Mutations: New Horizons from Tumor Molecular Profiling
por: Mafficini, Andrea, et al.
Publicado: (2021)

“Pure” hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms
por: Mattiolo, Paola, et al.
Publicado: (2022)

SNPnexus: a web database for functional annotation of newly discovered and public domain single nucleotide polymorphisms
por: Chelala, Claude, et al.
Publicado: (2009)

The Mutant p53-Driven Secretome Has Oncogenic Functions in Pancreatic Ductal Adenocarcinoma Cells
por: Butera, Giovanna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lk0k4u9p06at4nkep1mab0io39